Principal Investigators
MOCHEL Fanny
Institution
APHP
Contact information of lead PI
Country
France
Title of project or programme
Etude de phase IIa dans la maladie de Huntington visant à évaluer le potentiel thérapeutique du resvératrol. Phase IIa study in Huntington disease to evaluate the therapeutic potential of resveratrol
Source of funding information
DGOS
Total sum awarded (Euro)
517,807
Start date of award
xx/xx/2013
Total duration of award in years
3.0
The project/programme is most relevant to:
Huntington's disease
Keywords
Research Abstract
Lay Summary
Further information available at:
Types: Investments > €500k
Member States: France
Diseases: Huntington's disease
Years: 2016
Database Categories: N/A
Database Tags: N/A